Compare Organon Pharma Indonesia Tbk. (SCPI) vs Uni-Charm Indonesia Tbk. (UCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Uni-Charm Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Uni-Charm Indonesia Tbk. trades at Rp515 (market cap 2.14T, 2.52M 24h volume). The key difference: Uni-Charm Indonesia Tbk. is far larger — about 20.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | UCID | |
|---|---|---|
Market Cap | 104.4B | 2.14T |
Volume | — | 2.52M |
Lot | — | 25.17K |
Turnover | — | 1.3B |
Average Price | — | 518.01 |
Value | — | 1.3B |
Indicative Equilibrium Price | — | 515 |
Indicative Equilibrium Volume | — | 6 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Uni-Charm Indonesia Tbk.
PT Uni-Charm Indonesia Tbk (the Company) was established based on Notarial Deed No. 37 dated 5 June 1997 of Linda Herawati S.H. The Company commenced its commercial operation in February 1998. The Company and its Subsidiary (the Group) operates under Unicharm Group. The ultimate parent of the Group is Unicharm Corporation, domiciled in Japan.
Read more on UCID →
